Shorted
Polynovo logo

PNV

Polynovo

Health Care Equipment & Services

PolyNovo specializes in developing and commercializing advanced medical devices using its proprietary NovoSorb technology. The company focuses on treating burns, surgical wounds, and providing solutions for Negative Pressure Wound Therapy, positioning itself as a leader in innovative healthcare solutions.

Health Care
Medical Devices
Innovation
Burn Treatment

Shorted

short percentage12.47%
reported shorts86.2M
shares on issue690.843M

About

industry

Health Care Equipment & Services

address

Unit 2, 320 Lorimer Street, PORT MELBOURNE, VIC, AUSTRALIA, 3207

Connect

Key Metrics

market cap
$694.30M
p/e ratio50.25
eps$0.02

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Health Care
Medical Devices
Innovation
Burn Treatment
Wound Care

Company Overview

AI-generated company summary

PolyNovo specializes in developing and commercializing advanced medical devices using its proprietary NovoSorb technology. The company focuses on treating burns, surgical wounds, and providing solutions for Negative Pressure Wound Therapy, positioning itself as a leader in innovative healthcare solutions.

Company History

PolyNovo was founded to revolutionize the treatment of complex wounds and burns. Over the years, the company has evolved by leveraging its NovoSorb technology to create a range of medical devices. A major milestone was the successful commercialization of its products, which are now used globally in various healthcare settings.

Competitive Advantages

PolyNovo's competitive advantages include its proprietary NovoSorb technology, which offers unique benefits in wound healing and tissue regeneration. The company's focus on innovation and its ability to commercialize products globally also provide a significant edge in the healthcare market.

Risk Factors

  • Regulatory challenges
  • Market competition
  • Dependence on technology innovation

Recent Developments

Last 6 months

In the past six months, PolyNovo has expanded its market reach and continued to innovate its product offerings, enhancing its position in the healthcare industry.

Key People

Leadership team at Polynovo

HR

Healing. Redefined.

Focused on our mission to improve patient outcomes and reimagine the standard of care

Financial Reports

77 reports available

1H26 Results Presentation - Webcast Link

Investor PresentationFeb 12, 2026via asx_announcements

Notice of Annual General Meeting

Agm AddressSep 25, 2025via asx_announcements

FY25 Annual Report

Annual ReportSep 8, 2025via asx_announcements

Webcast Recording - FY25 Results Presentation

Investor PresentationAug 26, 2025via asx_announcements

Appendix 4E and FY25 Financial Statements

Annual ResultsAug 25, 2025via asx_announcements

FY25 Results Presentation

Investor PresentationAug 25, 2025via asx_announcements

Investor Presentation & Webcast Link

Investor PresentationMay 16, 2025via asx_announcements

Webcast Recording for the 1H FY25 Results Presentation

Investor PresentationFeb 25, 2025via asx_announcements

Appendix 4D & 1H FY25 Report

Half Year ResultsFeb 24, 2025via asx_announcements

1H FY25 Results Presentation

Investor PresentationFeb 24, 2025via asx_announcements

Showing 10 of 77 reports